Traditional enzyme engineering methods are slow, resource-intensive, and often fail to deliver enzymes with the desired performance characteristics for various industrial applications. The process requires extensive experimental data and manual optimization, limiting the speed and scalability of enzyme development.

Imperagen offers a fully automated, AI-driven platform for enzyme engineering that significantly accelerates the development and optimization of enzyme variants. Their Digital Enzyme Evolution™ platform integrates AI-powered hotspot identification, precision DNA editing, and laboratory automation to overcome the limitations of traditional methods. By combining predictive algorithms, generative gene design, and robotic workflows, Imperagen enables rapid creation and screening of enzyme variants with improved turnover, stability, and expression. The platform's seamless scalability and flexibility allow for the development of enzymes across diverse classes and performance parameters.

AI-powered hotspot identification using proprietary physics-based algorithms and high-performance computing

Generative gene design and smart DNA library creation optimized for assembly, mutation, and expression

Fully automated and digitalized laboratory workflow with integrated robotics

Ability to optimize multiple performance parameters, including turnover, stability, and expression

Seamless scalability to handle multiple projects simultaneously

Digital Enzyme Evolution™ platform combining AI, DNA editing, and automation

Imperagen's primary customers are companies in industries such as pharmaceuticals, biotechnology, and chemicals that require custom-engineered enzymes for their products or processes.